Learn more →
Back to Expert Scholars
dermatologic-oncology / dermatologic-oncologyCutaneous Squamous Cell Carcinoma

Chrysalyne Schmults

克莉萨林·施穆尔茨

MD, MSCE

🏢Brigham and Women's Hospital / Harvard Medical School(布莱根妇女医院/哈佛医学院)🌐USA

Director, High-Risk Skin Cancer Program; Associate Professor of Dermatology高危皮肤癌项目主任;皮肤科副教授

48
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Chrysalyne Schmults is the leading expert in high-risk cutaneous squamous cell carcinoma (cSCC) at Brigham and Women's Hospital, directing the nation's premier high-risk skin cancer program. She created the BWH tumor classification system for cSCC, advanced Mohs surgery outcomes research, and has shaped evidence-based guidelines for cSCC management.

Share:

🧪Research Fields 研究领域

Dermatologic Oncology皮肤肿瘤学
Cutaneous Squamous Cell Carcinoma皮肤鳞状细胞癌
Mohs Surgery莫氏手术
Skin Cancer Outcomes皮肤癌预后

🎓Key Contributions 主要贡献

cSCC Risk Stratification

Developed and validated the Brigham and Women's Hospital (BWH) tumor classification system for cutaneous squamous cell carcinoma, enabling superior identification of high-risk tumors compared to prior staging systems.

Mohs Surgery Outcomes Research

Led large-scale outcomes research on Mohs micrographic surgery for cSCC and basal cell carcinoma, defining cure rates, recurrence predictors, and optimal patient selection criteria.

Multidisciplinary High-Risk Skin Cancer Care

Established and directs the BWH High-Risk Skin Cancer Program, a multidisciplinary clinic model integrating dermatology, radiation oncology, and medical oncology for complex cSCC cases.

Representative Works 代表性著作

[1]

Development and Validation of a New American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma

Journal of Clinical Oncology (2011)

Proposed the BWH staging system demonstrating superior discrimination of high-risk cSCC compared to AJCC staging, now incorporated in clinical practice guidelines.

[2]

Tumor Upstaging Using the Brigham and Women's Hospital System for Cutaneous Squamous Cell Carcinoma Staging

JAMA Dermatology (2014)

Validated BWH staging system superiority in predicting nodal metastasis and disease-specific death across multi-institutional cohorts.

[3]

Outcomes of Mohs Surgery for Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

JAMA Dermatology (2013)

Established evidence-based benchmarks for Mohs surgery recurrence rates in cSCC, supporting guideline development for appropriate use criteria.

🏆Awards & Recognition 奖项与荣誉

🏆American College of Mohs Surgery Research Award
🏆Society for Investigative Dermatology Young Investigator Award
🏆Brigham and Women's Hospital Surgical Innovation Award
🏆American Academy of Dermatology Clinical Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 克莉萨林·施穆尔茨 的研究动态

Follow Chrysalyne Schmults's research updates

留下邮箱,当我们发布与 Chrysalyne Schmults(Brigham and Women's Hospital / Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment